MINIVELLE (estradiol) by Noven Pharmaceuticals is estrogen receptor agonists [moa]. First approved in 2012.
Drug data last refreshed 22h ago · AI intelligence enriched 1w ago
MINIVELLE is an extended-release transdermal estradiol film indicated for hormone replacement therapy in postmenopausal women. It delivers estrogen via a transdermal patch formulation, functioning as an estrogen receptor agonist to alleviate vasomotor symptoms and other menopausal manifestations. The extended-release mechanism provides steady-state hormone delivery while minimizing fluctuations.
Product remains in peak commercialization phase with modest Medicare utilization; brand team focus is on maintenance and lifecycle extension strategies.
Estrogen Receptor Agonists
Estrogen
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Evaluate the Effect of Vimseltinib on Pharmacokinetics of Combined Oral Contraceptive (Ethinyl Estradiol/Levonorgestrel)
A Trial to Examine the Interaction of Repinatrabit With Ethinyl Estradiol/Norethindrone, Metformin,Carbamazepine, Rosuvastatin, and Methotrexate When Administered Together
A Phase 1 Study to Assess the Effect of ABBV-722 on Ethinyl Estradiol and Levonorgestrel Drug Levels in Healthy Adult Female Participants
Estradiol-mediated Inflammation and Central Sensitization in the Pathophysiology of Endometriosis-associated Pelvic Pain
Drug-drug Interaction Study of Bemnifosbuvir/Ruzasvir (BEM/RZR) and Ethinyl Estradiol/Levonorgestrel (EE/LNG)
Worked on MINIVELLE at Noven Pharmaceuticals? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Upgrade to Pro to access patent cliff timelines and LOE dates and other premium pharma intelligence.
Upgrade to Pro — $25/moUpgrade to Pro to access Medicare Part D spending data and other premium pharma intelligence.
Upgrade to Pro — $25/moUpgrade to Pro to access CMS Part B ASP pricing data and other premium pharma intelligence.
Upgrade to Pro — $25/moNoven Pharmaceuticals is hiring 1 role related to this product
LOE in ~5 years — strategic planning for patent cliff underway
Career opportunities on MINIVELLE are heavily concentrated in manufacturing quality and technical operations, reflecting the mature product lifecycle and transdermal formulation complexity. This is ideal for operations-focused professionals seeking stability but offers limited commercial advancement.
8 open roles linked to this drug